Doxorubicin remains the most extensively used drug in the chemotherapy of thyroid cancer. However, drug resistance often limits the efficacy of chemotherapy in clinical practice. Several ...

复旦大学附属浦东医院普外科王晓亮教授团队在期刊《Cell Death Discovery》上发表了题为“SLC50A1 inhibits the doxorubicin sensitivity in hepatocellular carcinoma cells ...

In a cohort of 62 patients with HCC there were 141 sessions of TACE with DEB loaded with doxorubicin. [56] At 9 months of follow-up, the sustained objective response (European Association for the ...

Differences in mechanisms of action between paclitaxel, doxorubicin and cisplatin in breast cancer may be accompanied by a corresponding diversity in gene expression patterns. We analyzed gene ...

Hepatocellular carcinoma (HCC) stands as the dominant ... Chemotherapeutic agents used in TACE, such as doxorubicin, exhibit dual roles: inducing ICD and enhancing adaptive immune responses ...